Refine by
Pulmonary Embolism Articles & Analysis: Older
8 articles found
Hormone therapy also carries potential risks, such as a possible increased risk of cardiovascular events, breast cancer, deep vein thrombosis, pulmonary embolism, and gallbladder disease.Drugs That Promote Bone Formation(1) Parathyroid HormoneParathyroid hormone (PTH) as a bone formation promoter can effectively promote bone reconstruction, increase bone density, ...
Serious side effects include diarrhea, neutropenia, liver Examination of blood and coagulation (deep vein thrombosis / pulmonary embolism). In addition, Verzenio may cause harm to developing fetuses and is not suitable for pregnant women. 2. ...
But in half of cases, there are no signs of DVT until part of the clot breaks away and t ravels through the circulation to the heart and lungs, where it can cause a potentially fatal blockage called a pulmonary embolism (PE). Other signs of PE include unexplained shortness of breath, pain on breathing, coughing up blood and a fast heart rate – and it is ...
METHODS: The Triflo valve (size 21mm) was implanted in two models: 90 days in aortic position (n=7) and 70 days in pulmonary position (n=4). In the pulmonary model, On-X valves (n=2) were used as control. ...
Their BASHIR™ Endovascular Catheters are a series of pharmaco-mechanical endovascular catheters which physicians are beginning to use to treat their patients suffering from thromboembolic conditions, such as Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) with excellent clinical outcomes. At Silicon Review, we know that this type of focus is an ...
February 9, 2021—Findings from the first-in-human (FIH) study assessing the safety and feasibility of the Bashir endovascular catheter (BEC; Thrombolex, Inc.) for the treatment of acute intermediate-risk pulmonary embolism (PE) were published by Akhilesh K. Sista, MD, et al in Circulation: Cardiovascular Intervention (2021;14). ...
Up to 35% to 50% of patients with PE who are treated with anticoagulation therapy alone, experience post-PE syndrome, chronic thromboembolic disease (CTED) and chronic thromboembolic pulmonary hypertension (CTEPH). In addition, up to one third of these patients are readmitted to the hospital within the first ten years post treatment. ...
It can be used in conjunction with other auxiliary therapies to treats medical conditions that include: Skin and soft tissues diseases: Thermal burns, chemical burns, radiation burns Frostbite Scalds Skin infections (erysipelas, pyoderma, actinomycosis, aspergillosis, Gram negative bacteria infections, nosocomial infections) Dry skin Cutaneous ulceration (caused by vein insufficiency , ...